基本信息
浏览量:1
职业迁徙
个人简介
The inter- and intra-patient genetic heterogeneity of tumours means that different patients, with ostensibly the same tumour type, may respond differently to the same drug, and combinations of drugs may be needed in order to treat the multiple clones present within a tumour. We are developing molecular imaging methods to detect the early responses of tumours to treatment. These could be used in early stage clinical trials to get an early indication of drug efficacy and subsequently in the clinic to select the most effective drug, or drug combination, for individual patients. We have focused on methods for imaging tumour metabolism, which can give an early indication of whether a drug has engaged its target, and on methods for imaging the downstream consequences of this engagement, notably tumour cell death.
研究兴趣
论文共 416 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jacob Chen Ming Low,Jianbo Cao,Friederike Hesse,Alan J Wright,Anastasia Tsyben, Islam Alshamleh,Richard Mair,Kevin M Brindle
Cancer research (2024)
Methods in molecular biology (Clifton, N.J.) (2024): 221-231
引用0浏览0WOS引用
0
0
Molecular Imaging and Biologyno. 2 (2024): 222-232
npj Imagingno. 1 (2024): 1-5
Jacob G. Bundy,N. Gopalakrishna Iyer, Michelle S. Gentile, De-En Hu,Mikko Kettunen,Ana-Teresa Maia,Natalie P. Thorne,James D. Brenton,Carlos Caldas,Kevin M. Brindle
crossref(2023)
Richard Mair,Alan J. Wright,Susana Ros, De-en Hu,Tom Booth,Felix Kreis, Jyotsna Rao,Colin Watts,Kevin M. Brindle
crossref(2023)
Cancersno. 5 (2023): 1564-1564
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn